相关实验视频

Updated: Jan 8, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

设计,合成和结构-活动关系的新型人类TLR1/2对潜在的免疫治疗的激动剂

Qiuyue Fu¹, Yue Pan¹, Peixi Wu¹

¹Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Journal of medicinal chemistry

|December 15, 2025

概括

研究人员开发了SMU-C409,它是用于癌症治疗的强效和低毒性Toll-like受体2 (TLR2) 激动剂. 这种新型化合物增强了稳定性和溶解性,为有效的癌症免疫疗法显示了希望.

科学领域:

免疫学免疫学免疫学
药用化学医学化学
药理学药理学是指药理学的学科.

背景情况:

托尔类受体2 (TLR2) 激动剂在癌症治疗中具有潜在的潜力,这是由于其高强度和低毒性.
现有的TLR2激动剂面临着降解和溶解性差等局限性,阻碍了它们的临床应用.

研究的目的:

设计和合成基于硫尿素的新型TLR2激动剂,具有改善的药理动力学特性.
为癌症免疫治疗确定一种低毒性,强效和稳定的TLR1/2特异性小分子激动剂.

主要方法:

设计和合成一系列基于硫尿素的TLR2激动剂.
关于SMU-C409的功效 (EC50),稳定性,可溶性和作用机制的表征.
在体外评估免疫细胞激活和抗瘤免疫调节.

主要成果:

确定了SMU-C409,一种TLR1/2特异性激动剂,EC50=65±3nM.
SMU-C409的特点是碳烯保护策略和氨酸部分,以提高稳定性和可溶性 (3.4倍自由基,5.5倍化物).
机制研究证实了TLR1/2激活,MyD88招募,NF-κB酸化和TNF-α/IL-1β分泌,以及强大的体外免疫细胞激活和抗瘤作用.

结论:

SMU-C409克服了先前的TLR2激动剂的关键局限性,显示出高强度,改善稳定性和可溶性.
通过免疫调节,SMU-C409作为促进癌症免疫治疗的候选人具有显著的潜力.

更多相关视频

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...